Home LiteratureArticle Details
PMID: 7534227 Published · ppublish English Journal Article

Gelatinase A activity directly modulates melanoma cell adhesion and spreading.

The EMBO journal ·Vol. 14 ·No. 5 ·1995-03-01 ·Pages 908-17

Ray JM, Stetler-Stevenson WG

Abstract

Interaction of cells with the extracellular matrix (ECM) plays an important role in the regulation of cell behavior. Formation of adhesive contacts leads to transduction of signals into the cell and results in altered gene expression and modulation of the cellular phenotype. Specific adhesive interactions of the fibronectin and vitronectin receptors with their ligands in the matrix modulates expression of ECM-degrading metalloproteases. These proteases are involved in the acquisition of the invasive phenotype by a number of cell types. The activity of matrix metalloproteases (MMPs) is reduced by endogenous inhibitors referred to as tissue inhibitors of metalloproteases (TIMPs). Alterations in the balance between the activity of MMPs and TIMPs alters cellular invasion through effects on matrix degradation. In this study we demonstrate that inhibition of endogenous gelatinase A activity in A2058 human melanoma cells results in enhanced cellular adhesion. To further explore this phenomenon, we have used retroviral infection vectors to control the amount of the MMP inhibitor TIMP-2 in human melanoma A2058 cells. Altering the production of TIMP-2 modulates not only proteolysis of the extracellular matrix, but also the adhesive and spreading properties of the cells and results in altered cell morphology. These effects of TIMP-2 appear to be mediated by inhibition of gelatinase A activity. We conclude that gelatinase A, in addition to contributing to proteolysis of ECM components, also functions to proteolyse cell surface components that mediate attachment of A2058 cells to the ECM. Thus, gelatinase A may function to modulate cell attachment and facilitate cell migration and invasion.

MeSH Terms
Cell Adhesion/drug effects,physiology Cell Movement/physiology Extracellular Matrix/metabolism Extracellular Matrix Proteins/metabolism Fibronectins/metabolism Gelatin/metabolism Gelatinases/antagonists & inhibitors,metabolism,pharmacology Gene Expression Regulation, Viral Genetic Vectors/genetics Glycoproteins/metabolism Humans Leukemia Virus, Murine/genetics Matrix Metalloproteinase 2 Melanoma/metabolism,pathology Metalloendopeptidases/antagonists & inhibitors,metabolism,pharmacology Protein Biosynthesis Proteins/genetics,pharmacology Tissue Inhibitor of Metalloproteinase-2 Tumor Cells, Cultured Vitronectin
Chemicals
Extracellular Matrix Proteins Fibronectins Glycoproteins Proteins Vitronectin Tissue Inhibitor of Metalloproteinase-2 Gelatin Gelatinases Metalloendopeptidases Matrix Metalloproteinase 2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ray J M
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Stetler-Stevenson W G
References (52)
52 references, click to expand
  1. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
    J Biol Chem. 1989 Jan 25;264(3):1353-6 PMID: 2536363
  2. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.
    J Cell Biol. 1994 May;125(3):681-93 PMID: 8175886
  3. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion.
    J Cell Biol. 1989 Jun;108(6):2435-47 PMID: 2661563
  4. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.
    J Cell Biol. 1989 Aug;109(2):877-89 PMID: 2547805
  5. Metalloproteinases and cancer invasion and metastasis.
    Int J Cancer. 1989 Oct 15;44(4):757-60 PMID: 2793248
  6. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells.
    Cancer Res. 1990 Mar 1;50(5):1601-7 PMID: 2406015
  7. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.
    J Natl Cancer Inst. 1990 Apr 4;82(7):589-95 PMID: 2156082
  8. Improved retroviral vectors for gene transfer and expression.
    Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 PMID: 2631796
  9. Identification of an inhibitor of neovascularization from cartilage.
    Science. 1990 Jun 15;248(4961):1408-10 PMID: 1694043
  10. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Int J Cancer. 1990 Jul 15;46(1):56-60 PMID: 2142142
  11. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.
    Cell. 1990 Aug 10;62(3):435-45 PMID: 2379237
  12. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development.
    Curr Top Dev Biol. 1990;24:219-59 PMID: 2199157
  13. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.
    J Biol Chem. 1990 Aug 15;265(23):13933-8 PMID: 2380196
  14. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
    J Cell Biol. 1990 Aug;111(2):743-55 PMID: 1696269
  15. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Cancer Res. 1990 Oct 1;50(19):6184-91 PMID: 2169338
  16. Motility factor produced by malignant glioma cells: role in tumor invasion.
    J Neurosurg. 1990 Dec;73(6):881-8 PMID: 2230971
  17. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.
    J Biol Chem. 1990 Dec 5;265(34):21141-51 PMID: 2174435
  18. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.
    Cancer Res. 1991 Jan 1;51(1):439-44 PMID: 1846313
  19. Tumour progression and the nature of cancer.
    Br J Cancer. 1991 Oct;64(4):631-44 PMID: 1911211
  20. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells.
    Int J Cancer. 1991 Nov 11;49(5):717-20 PMID: 1657797
  21. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.
    Cancer Res. 1992 Feb 1;52(3):701-8 PMID: 1732058
  22. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.
    Biochemistry. 1992 Feb 18;31(6):1665-72 PMID: 1310615
  23. Role of the alpha v beta 3 integrin in human melanoma cell invasion.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1557-61 PMID: 1371877
  24. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.
    J Biol Chem. 1992 Aug 5;267(22):15398-405 PMID: 1322396
  25. Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.
    J Cell Biol. 1992 Aug;118(3):727-39 PMID: 1639854
  26. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells.
    Int J Cancer. 1992 Oct 21;52(4):653-7 PMID: 1399148
  27. Physiological mechanisms for metalloproteinase activation.
    Matrix Suppl. 1992;1:224-30 PMID: 1480031
  28. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2).
    Biochemistry. 1993 Feb 16;32(6):1583-92 PMID: 8431437
  29. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.
    Kidney Int. 1993 Jan;43(1):163-70 PMID: 8433556
  30. Matrix metalloproteinases: a review.
    Crit Rev Oral Biol Med. 1993;4(2):197-250 PMID: 8435466
  31. Mechanisms of placental invasion of the uterus and their control.
    Biochem Cell Biol. 1992 Oct-Nov;70(10-11):867-74 PMID: 1297352
  32. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
    J Biol Chem. 1993 Jul 5;268(19):14033-9 PMID: 8314771
  33. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.
    J Clin Pathol. 1993 May;46(5):429-36 PMID: 8391548
  34. Metastatic potential correlates with enzymatic degradation of basement membrane collagen.
    Nature. 1980 Mar 6;284(5751):67-8 PMID: 6243750
  35. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.
    Proc Natl Acad Sci U S A. 1980 Sep;77(9):5258-62 PMID: 6254071
  36. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.
    J Biol Chem. 1986 Oct 25;261(30):14245-55 PMID: 3095317
  37. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.
    Cell. 1986 Nov 21;47(4):487-98 PMID: 3022933
  38. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
    Cancer Res. 1987 Sep 15;47(18):4869-76 PMID: 3621180
  39. Thermal stability of human-fibroblast-collagenase-cleavage products of type-I and type-III collagens.
    Biochem J. 1987 Nov 1;247(3):725-9 PMID: 2827636
  40. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
    J Cell Biol. 1988 Mar;106(3):925-30 PMID: 2450101
  41. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
    Cancer Res. 1988 Oct 1;48(19):5539-45 PMID: 3416307
  42. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells.
    Anal Biochem. 1988 Aug 15;173(1):93-5 PMID: 2461121
  43. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
    Cell. 1991 Jan 25;64(2):327-36 PMID: 1703045
  44. Tumor cell invasion inhibited by TIMP-2.
    J Natl Cancer Inst. 1991 Jun 5;83(11):775-9 PMID: 1645772
  45. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.
    Cancer Metastasis Rev. 1990 Dec;9(4):353-67 PMID: 2129023
  46. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.
    Cancer Res. 1993 Jul 15;53(14):3411-5 PMID: 7686818
  47. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
    J Cell Physiol. 1993 Aug;156(2):235-46 PMID: 8344982
  48. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.
    J Cell Physiol. 1993 Nov;157(2):351-8 PMID: 7693724
  49. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.
    FASEB J. 1993 Dec;7(15):1434-41 PMID: 8262328
  50. Tumor cell interactions with the extracellular matrix during invasion and metastasis.
    Annu Rev Cell Biol. 1993;9:541-73 PMID: 8280471
  51. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization.
    Am J Pathol. 1994 Mar;144(3):518-27 PMID: 8129037
  52. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells.
    Science. 1989 Feb 17;243(4893):947-50 PMID: 2465572
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1995-03-01
Pages
908-17
Language
English
Region
England
NLM ID
8208664
PMCID
PMC398163
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]